Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Montazeri

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Singapore Medical Journal|July 28, 2007
Pre-emptive gabapentin significantly reduces postoperative pain and morphine demand following lower extremity orthopaedic surgeryK Montazeri, P Kashefi, A Honarmand
Singapore Medical Journal|July 27, 2010
Fatality in paraquat poisoningA M Sabzghabaee, N Eizadi-Mood, K Montazeri, et al.
Melanoma Research|April 5, 2024
Impact of gene expression profiling on diagnosis and survival after metastasis in patients with uveal melanomaD Suwajanakorn, A M Lane, A K Go, et al.
Urologic Oncology|June 24, 2021
An economic analysis comparing health care resource use and cost of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin versus gemcitabine and cisplatin as neoadjuvant therapy for muscle invasive bladder cancerK Montazeri, G Dranitsaris, J D Thomas, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Singapore Medical Journal|July 28, 2007
Pre-emptive gabapentin significantly reduces postoperative pain and morphine demand following lower extremity orthopaedic surgeryK Montazeri, P Kashefi, A Honarmand
Singapore Medical Journal|July 27, 2010
Fatality in paraquat poisoningA M Sabzghabaee, N Eizadi-Mood, K Montazeri, et al.
Melanoma Research|April 5, 2024
Impact of gene expression profiling on diagnosis and survival after metastasis in patients with uveal melanomaD Suwajanakorn, A M Lane, A K Go, et al.
Urologic Oncology|June 24, 2021
An economic analysis comparing health care resource use and cost of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin versus gemcitabine and cisplatin as neoadjuvant therapy for muscle invasive bladder cancerK Montazeri, G Dranitsaris, J D Thomas, et al.
Pageof 1